Bioreactors in tissue engineering - principles, applications and commercial constraints

被引:67
作者
Hansmann, Jan [1 ]
Groeber, Florian [2 ]
Kahlig, Alexander [2 ]
Kleinhans, Claudia [2 ]
Walles, Heike [1 ,3 ]
机构
[1] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Dept Cell & Tissue Engn, Stuttgart, Germany
[2] Univ Stuttgart, Inst Interfacial Engn IGVT, D-70569 Stuttgart, Germany
[3] Univ Wurzburg, Inst Tissue Engn & Regenerat Med, Wurzburg, Germany
关键词
Applications; Bioreactor; Commercial Aspects; Red/medical biotechnology; Tissue engineering; MESENCHYMAL STEM-CELLS; FLOW PERFUSION BIOREACTOR; BED SYSTEM BIOREACTOR; BONE TISSUE; IN-VITRO; SUSPENSION-CULTURE; SHEAR-STRESS; OSTEOGENIC DIFFERENTIATION; VESSEL BIOREACTOR; FLASK BIOREACTOR;
D O I
10.1002/biot.201200162
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Bioreactor technology is vital for tissue engineering. Usually, bioreactors are used to provide a tissue-specific physiological in vitro environment during tissue maturation. In addition to this most obvious application, bioreactors have the potential to improve the efficiency of the overall tissue-engineering concept. To date, a variety of bioreactor systems for tissue-specific applications have been developed. Of these, some systems are already commercially available. With bioreactor technology, various functional tissues of different types were generated and cultured in vitro. Nevertheless, these efforts and achievements alone have not yet led to many clinically successful tissue-engineered implants. We review possible applications for bioreactor systems within a tissue-engineering process and present basic principles and requirements for bioreactor development. Moreover, the use of bioreactor systems for the expansion of clinically relevant cell types is addressed. In contrast to cell expansion, for the generation of functional three-dimensional tissue equivalents, additional physical cues must be provided. Therefore, bioreactors for musculoskeletal tissue engineering are discussed. Finally, bioreactor technology is reviewed in the context of commercial constraints.
引用
收藏
页码:298 / 307
页数:10
相关论文
共 109 条
[51]   Spatial patterning of cell proliferation and differentiation depends on mechanical stress magnitude [J].
Li, Bin ;
Li, Fang ;
Puskar, Kathleen M. ;
Wang, James H-C. .
JOURNAL OF BIOMECHANICS, 2009, 42 (11) :1622-1627
[52]   Cell culture processes for monoclonal antibody production [J].
Li, Feng ;
Vijayasankaran, Natarajan ;
Shen, Amy ;
Kiss, Robert ;
Amanullah, Ashraf .
MABS, 2010, 2 (05) :466-479
[53]   Angiogenesis: regulators and clinical applications [J].
Liekens, S ;
De Clercq, E ;
Neyts, J .
BIOCHEMICAL PHARMACOLOGY, 2001, 61 (03) :253-270
[54]   Study of hydroxyapatite osteoinductivity with an osteogenic differentiation of mesenchymal stem cells [J].
Lin, Liwen ;
Chow, L. ;
Leng, Yang .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2009, 89A (02) :326-335
[55]   Expansion and Differentiation of Human Embryonic Stem Cells to Endoderm Progeny in a Microcarrier Stirred-Suspension Culture [J].
Lock, Lye T. ;
Tzanakakis, Emmanuel S. .
TISSUE ENGINEERING PART A, 2009, 15 (08) :2051-2063
[56]  
Lujan TJ, 2011, TISSUE ENG PART C-ME, V17, P367, DOI [10.1089/ten.tec.2010.0381, 10.1089/ten.TEC.2010.0381]
[57]   Tissue engineering: The end of the beginning [J].
Lysaght, MJ ;
Hazlehurst, AL .
TISSUE ENGINEERING, 2004, 10 (1-2) :309-320
[58]   Mechanical control of tissue and organ development [J].
Mammoto, Tadanori ;
Ingber, Donald E. .
DEVELOPMENT, 2010, 137 (09) :1407-1420
[59]   Commercial considerations in tissue engineering [J].
Mansbridge, Jonathan .
JOURNAL OF ANATOMY, 2006, 209 (04) :527-532
[60]   The role of bioreactors in tissue engineering [J].
Martin, I ;
Wendt, D ;
Heberer, M .
TRENDS IN BIOTECHNOLOGY, 2004, 22 (02) :80-86